comparemela.com
Home
Live Updates
Alkermes Issues Letter to Shareholders Highlighting Skills a
Alkermes Issues Letter to Shareholders Highlighting Skills a
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company's upcoming 2023 Annual...
Related Keywords
Iron Mountain ,
New York ,
United States ,
Dublin ,
Ireland ,
Ohio ,
Athlone ,
Westmeath ,
Massachusetts ,
Canada ,
Innisfree ,
Sligo ,
Waltham ,
Irish ,
Davida Daglio ,
Wilda Van Dusen ,
W Montague Cobb ,
Nancyj Wysenski ,
Eli Lilly ,
Shanem Cooke ,
Emily Peterson ,
Andy Wilson ,
Richard Gaynor ,
Katie Joyce ,
Catot Laurencin ,
Frank Anders Wilson ,
Alexander Denner ,
Sarahj Schlesinger ,
Nancyl Snyderman ,
America Ph ,
David Daglio ,
Christopher Wright ,
Shane Cooke ,
Sarah Schlesinger ,
Brianp Mckeon ,
Alexj Denner ,
Cato Laurencin ,
Chris Kittredge Zachary Tramonti ,
Patrice Bonfiglio ,
Brian Mckeon ,
Emily Peterson Alva ,
Richardb Gaynor ,
Christopheri Wright ,
Nancy Wysenski ,
Professor Of Neurology At Harvard Medical School ,
Pembroke Capital ,
Clinical Development ,
Neon Therapeutics Inc ,
Africana Studies Institute ,
Infinity Pharmaceuticals Inc ,
Catot Laurencin Institute For Regenerative Engineering ,
Emergent Biosolutions Inc ,
Prothena Corporation ,
Biotechnology Innovation Organization ,
Acadia Pharmaceuticals Inc ,
University Of Connecticut Uconn ,
Elan Corporation ,
Leap Therapeutics Inc ,
Health Institute ,
Mimedx Group Inc ,
Company Annual Report On Form ,
Affairs Of Lilly Oncology ,
Vertex Pharmaceuticals Incorporated ,
Corporate Governance Committee ,
Axcella Health Inc ,
Lazard ,
Laboratories Inc ,
Harvard Medical School Board Of Fellows ,
Aavantibio Inc ,
Acceleron Pharma Inc ,
Jazz Pharmaceuticals ,
Exelixis Inc Incyte Corporation ,
School Of Medicine ,
Sage Therapeutics Inc ,
Head Of Translational Research Ring Therapeutics ,
Damon Runyon Cancer Research Foundation ,
United Therapeutics Corporation ,
Sarepta Therapeutics Inc ,
Mission Society Of New York City ,
Ultragenyx Pharmaceutical Inc ,
Pepsico Inc ,
National Health Council ,
Therapeutics Inc ,
Zai Lab ,
Alnylam Pharmaceuticals Inc ,
Company Or Alkermes ,
University Professor ,
Ethnic Health Disparities ,
Global Medicines Development ,
Endo International ,
Neurocrine Biosciences Inc ,
Biontech Us Inc ,
Ironwood Pharmaceuticals Inc ,
Cyclerion Therapeutics Inc ,
Epizyme Inc ,
Timberland Company ,
Nasdaq ,
Iron Mountain Incorporated ,
Denner ,
Nominees On Company ,
Ionis Pharmaceuticals Inc ,
Exchange Commission ,
Blueprint Medicines Corporation ,
Alkermes ,
Innisfree Ma Incorporated ,
Amneal Pharmaceuticals Inc ,
Shareholders Vote ,
Director Nominees ,
General Meeting ,
Annual Meeting ,
Alkerme Value Enhancement Plan ,
Sarissa Capital Management ,
Richard Pops ,
Alkermes Shareholder ,
Value Enhancement Plan ,
Annual General Meeting ,
Elliott Management ,
Lead Independent ,
Key Roles ,
Advisory Experience ,
Amneal Pharmaceuticals ,
Emission Society ,
New York City ,
Elan Drug Technologies ,
Executive Vice President ,
Chief Financial Officer ,
Chief Executive ,
Pembroke Capital Limited ,
Neon Therapeutics ,
Senior Vice President ,
Medical Affairs ,
Lilly Oncology ,
Simmons Cancer Center ,
Texas Southwestern Medical School ,
Infinity Pharmaceuticals ,
Zai Lab Limited ,
Leap Therapeutics ,
Wilda Van Dusen Distinguished Endowed Professor ,
Orthopaedic Surgery ,
Biomolecular Engineering ,
Materials Science ,
Biomedical Engineering ,
Chief Executive Officer ,
Regenerative Engineering ,
Founding Chair ,
Mimedx Group ,
Vice President ,
North America ,
Prescription Drug User Fee Act ,
Polaris Venture Partners ,
Harvard Medical School Board ,
Neurocrine Biosciences ,
Pharmaceutical Research ,
Acceleron Pharma ,
Chief Medical Officer ,
Translational Research ,
Ring Therapeutics ,
Cyclerion Therapeutics ,
Chief Development Officer ,
Ironwood Pharmaceuticals ,
Axcella Health ,
Associate Professor ,
Harvard Medical School ,
Scientific Advisor ,
Interactions Between Sarissa ,
Alkermes Independent Directors ,
Lead Independent Director Nancy Wysenski ,
Sarissa Designee ,
Sarissa Nominees ,
Chief Investment Officer ,
Current Refreshed Board ,
Not Truly Independent ,
Current Refreshed ,
Alkerme Board ,
Alkermes Board ,
Private Securities Litigation Reform Act ,
Annual Report ,
Additional Information ,
Alnylam Pharmaceuticals ,
Incyte Corporation ,
Ionis Pharmaceuticals ,
Sage Therapeutics ,
Sarepta Therapeutics ,
United Therapeutics ,